UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011590
Receipt number R000013549
Scientific Title A prospective study of diagnostic accuracy of EUS-FNA for pancreatic solid lesion with conventional needle using slow pull technique
Date of disclosure of the study information 2013/08/27
Last modified on 2020/04/14 10:59:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective study of diagnostic accuracy of EUS-FNA
for pancreatic solid lesion with conventional needle using slow pull technique

Acronym

SP study

Scientific Title

A prospective study of diagnostic accuracy of EUS-FNA
for pancreatic solid lesion with conventional needle using slow pull technique

Scientific Title:Acronym

SP study

Region

Japan


Condition

Condition

pancreatic solid lesion

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the diagnostic accuracy of EUS-FNA
for pancreatic solid lesion with conventional needle using slow pull technique

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the diagnostic accuracy of EUS-FNA using slow pull technique

Key secondary outcomes

the diagnostic accuracy of each needle pass


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Maneuver

Interventions/Control_1

EUS-FNA using slow pull technique

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Pancreatic solid lesions confirmed by imaging modalities

Key exclusion criteria

Presence of severe comorbidities, coagulopathy
Inability to detect pancreatic solid lesion by EUS
Inability to obtain informed consent

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Kin
Middle name
Last name Toshifumi

Organization

Teine-Keijinkai Hospital

Division name

Center for Gastroenterology

Zip code

006-8555

Address

1-jo 12-chome, Maeda, Tiene-ku, Sapporo

TEL

011-681-8111

Email

kin_toshifumi@yahoo.co.jp


Public contact

Name of contact person

1st name Kin
Middle name
Last name Toshifumi

Organization

Teine-Keijinkai Hospital

Division name

Center for Gastroenterology

Zip code

006-8555

Address

1-jo 12-chome, Maeda, Tiene-ku, Sapporo

TEL

011-681-8111

Homepage URL


Email

kin_toshifumi@yahoo.co.jp


Sponsor or person

Institute

Teine-Keijinkai Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Teine-Keijinkai Hospital

Address

1-jo 12-chome, Maeda, Tiene-ku, Sapporo

Tel

011-681-8111

Email

teine@keijinkai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 27 Day


Related information

URL releasing protocol

NA

Publication of results

Published


Result

URL related to results and publications

NA

Number of participants that the trial has enrolled

40

Results

The diagnostic accuracy of SP-FNA was 90% (36/40). There was no significant difference in the accuracy between SP-FNA and SA-FNA (90% vs. 90%, p = 1.000). The samples obtained using SP-FNA were assessed as Grade 2 for quantity in 29 cases (73%), quality in 31 (78%), and blood contamination in 25 (63%).

Results date posted

2020 Year 04 Month 14 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Patients with a pancreatic solid lesion

Participant flow

prospectively enrolled

Adverse events

Not observed

Outcome measures

diagnostic accuracy, quantity, quality, and blood contamination level

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 01 Day

Date of IRB

2013 Year 04 Month 23 Day

Anticipated trial start date

2013 Year 04 Month 23 Day

Last follow-up date

2013 Year 08 Month 31 Day

Date of closure to data entry

2013 Year 08 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 08 Month 27 Day

Last modified on

2020 Year 04 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013549


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name